Bik and Bcl-2 regulate Nuclear Factor-kappaB-mediated inflammation

Bik 和 Bcl-2 调节核因子 kappaB 介导的炎症

基本信息

项目摘要

 DESCRIPTION (provided by applicant): Chronic inflammation and mucous cell metaplasia are common pathologic features of the majority of pulmonary diseases, including allergic asthma, pneumonia, and chronic bronchitis. The number of metaplastic mucous cells is regulated by Bcl-2 family-mediated cell death, specifically Bcl-2 and Bcl-2 interacting killer (Bik), in airway epithelia. However, it is not known whether Bcl-2 and Bik regulate inflammation, or the mechanism by which this regulation occurs. Preliminary results demonstrated that cigarette smoke -induced inflammation is significantly increased in bik-/- compared to bik+/+ mice, shown by increased numbers of macrophages and lymphocytes in the lung. Additionally, transgenic expression of Bik in airway epithelia significantly attenuated allergen-induced eosinophilia in comparison to controls, demonstrating an anti- inflammatory role for Bik. In order to determine of Bik modulates inflammation through inhibition of the pro- inflammatory transcription factor, Nuclear Factor-kappaB (NF-κB), its activation was assessed after adenoviral expression of GFP, wild type Bik, mutant Bik (BH3mutBik, Leucine 61to alanine substitution renders Bik unable to induce cell death), or a peptide containing the mutant BH3 domain of Bik . Interestingly, expression of both Bik and BH3mutBik equally in an airway cell line suppressed NF-κB activation in response to TNF-α stimulation. Inhibition of NF-κB in the presence of BH3mutBik occurred in conjunction with NF-κB's association with Bcl-2, a known binding partner of Bik. Because Bik and Bcl-2 associate via their BH3 domains, the effect on NF-κB activation was examined after blocking of the BH3 domain in Bcl-2 using the BH3 mimetic, ABT-263. ABT-263 reduced activation of NF-κB and enhanced its association to Bcl-2 in comparison to controls. Collectively, these data suggest that binding of the BH3 domain of Bcl-2, either by Bik or a BH3 mimetic, blocks nuclear translocation of NF-κB and inflammation. Specific aims of this proposal will (1) demonstrate the molecular mechanism by which Bik and Bcl-2 regulate NF-κB activation and inflammation and (2) test the role of Bik and Bcl-2 following House Dust Mite (HDM)-induced inflammation in vivo. Expression of Bik and Bcl-2 will be modulated in in vitro airway epithelial models, and Bik/Bcl-2 peptides and truncation mutants will be generated in order to test their impact on NF-κB activation. Additionally, adenoviral constructs of Bik and BH3mutBik, and ABT-263, will be administered in the mouse lung during HDM exposure to evaluate their impact on HDM-induced inflammation. According to the hypothesis, it is anticipated that both overexpression of BH3mutBik and inhibition of Bcl-2 will dampen HDM-induced inflammation in the lung. Based on preliminary data demonstrating that the BH3mutBik dampens NF-κB signaling independent of cell death, a novel role for Bcl-2 proteins will be established. Completion of these aims will not only delineate a novel mechanism for Bcl- 2 proteins and NF-κB signaling, but will also result in highly relevant translational research for inflammatory diseases of the lung.
 描述(由适用提供):慢性炎症和粘液细胞化生是大多数肺部疾病的常见病理特征,包括过敏性哮喘,肺炎和慢性支气管炎。在气道上皮中,Bcl-2家族介导的细胞死亡(特异性BCL-2和BCL-2相互作用杀手(BIK))调节化生粘膜细胞的数量。但是,尚不清楚Bcl-2和BIK是否调节炎症,或该调节发生的机制。初步结果表明,与Bik+/+小鼠相比,BIK - / - 中烟雾诱导的感染显着增加,这显示出肺中巨噬细胞和淋巴细胞数量的增加。此外,与对照相比,BIK在气道上皮中的转基因表达显着减弱了过敏原诱导的嗜酸性粒细胞,这表明BIK具有抗炎作用。 In order to determine Bik modulations injection through inhibition of the pro-inflammatory transcription factor, Nuclear Factor-kappaB (NF-κB), its activation was assessed after adenoviral expression of GFP, wild type Bik, mutant Bik (BH3mutBik, Leucine 61to alanine substitution renders Bik unable to induce cell death), or a peptide containing the mutant BH3 domain of Bik .有趣的是,在气道细胞系中,Bik和BH3Mutbik的表达同样地抑制了NF-κB激活,响应TNF-α刺激。在BH3Mutbik存在下NF-κB的抑制作用与NF-κB与BCL-2的关联(BCL-2)的关联(BCL-2)是BCL-2(BIK的已知结合伙伴)。由于BIK和BCL-2通过其BH3结构域关联,因此使用BH3 Mimetic,ABT-263在BCL-2中阻断BH3域后对NF-κB激活的影响进行了检查。与对照组相比,ABT-263降低了NF-κB的激活,并增强了其与Bcl-2的关联。总的来说,这些数据表明,BCC-2的BH3结构域的结合,无论是BIK还是BH3 MIMETIC,都会阻止NF-κB和炎症的核易位。该提案的具体目的(1)证明了BIK和BCL-2调节NF-κB激活和炎症的分子机制,以及(2)测试BIK和BCL-2在体内诱导的house dust mite(HDM)诱导的炎症之后的作用。 BIK和BCL-2的表达将在体外气道上皮模型中进行调节,并且将生成Bik/Bcl-2 Pepperides和截断突变体,以测试其对NF-κB激活的影响。此外,在HDM暴露期间,将在小鼠肺中施用BIK和BH3Mutbik和ABT-263的腺病毒构建体,以评估其对HDM诱导的炎症的影响。根据该假设,预计BH3Mutbik的过度表达和Bcl-2的抑制作用都会使HDM诱导的肺部炎症。基于初步数据,表明BH3Mutbik DAMBS NF-κB信号独立于细胞死亡,将确定Bcl-2蛋白的新作用。这些目标的完成不仅会描绘出Bcl-2蛋白和NF-κB信号传导的新型机制,而且还将导致对肺部炎症性疾病的高度相关的转化研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jane Tully Jones其他文献

307 - GSTP Modulates NF-kB Activation and Pro-Inflammatory Responses in Lung Epithelial Cells
  • DOI:
    10.1016/j.freeradbiomed.2015.10.357
  • 发表时间:
    2015-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    Jane Tully Jones;David Howard McMillan;Xi Qian;Karolyn Lahue;Jos van der Velden;Kenneth Tew;Yvonne Janssen-Heininger
  • 通讯作者:
    Yvonne Janssen-Heininger

Jane Tully Jones的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jane Tully Jones', 18)}}的其他基金

Bik and Bcl-2 regulate Nuclear Factor-kappaB-mediated inflammation
Bik 和 Bcl-2 调节核因子 kappaB 介导的炎症
  • 批准号:
    9331348
  • 财政年份:
    2016
  • 资助金额:
    $ 0.14万
  • 项目类别:

相似国自然基金

环D-脯氨酸D-苯丙氨酸对金黄色葡萄球菌的受体定位及对能量代谢影响
  • 批准号:
    31460425
  • 批准年份:
    2014
  • 资助金额:
    52.0 万元
  • 项目类别:
    地区科学基金项目
NO对采后桃果实苯丙氨酸代谢的影响及其与诱导抗病性形成的关系
  • 批准号:
    31101371
  • 批准年份:
    2011
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目
日粮酪氨酸、苯丙氨酸、色氨酸对泰和乌鸡合成黑色素影响及其适宜供给量、理想模式研究
  • 批准号:
    30660129
  • 批准年份:
    2006
  • 资助金额:
    21.0 万元
  • 项目类别:
    地区科学基金项目
苯丙氨酸影响钙/Rho GTPases信号通路的机制研究
  • 批准号:
    30570689
  • 批准年份:
    2005
  • 资助金额:
    25.0 万元
  • 项目类别:
    面上项目
酵母丙氨酸tRNA的结构改变对蛋白质生物合成的影响
  • 批准号:
    39070229
  • 批准年份:
    1990
  • 资助金额:
    5.0 万元
  • 项目类别:
    面上项目

相似海外基金

Perfluoroalkyl substances and non-alcoholic fatty liver disease in children: Leveraging magnetic resonance imaging to unravel potential mechanisms and exposure mixture effects
全氟烷基物质与儿童非酒精性脂肪肝:利用磁共振成像揭示潜在机制和暴露混合物效应
  • 批准号:
    10646759
  • 财政年份:
    2023
  • 资助金额:
    $ 0.14万
  • 项目类别:
High-throughput thermodynamic and kinetic measurements for variant effects prediction in a major protein superfamily
用于预测主要蛋白质超家族变异效应的高通量热力学和动力学测量
  • 批准号:
    10752370
  • 财政年份:
    2023
  • 资助金额:
    $ 0.14万
  • 项目类别:
The role of S-glutathione in regulating cardiac myosin binding protein-C function
S-谷胱甘肽在调节心肌肌球蛋白结合蛋白-C功能中的作用
  • 批准号:
    10749281
  • 财政年份:
    2023
  • 资助金额:
    $ 0.14万
  • 项目类别:
Defining cell intrinsic and extrinsic regulators of ferroptosis in pancreatic cancer
定义胰腺癌铁死亡的细胞内在和外在调节因子
  • 批准号:
    10679812
  • 财政年份:
    2023
  • 资助金额:
    $ 0.14万
  • 项目类别:
Ryanodine receptor structure and function in heart failure
Ryanodine 受体结构和心力衰竭中的功能
  • 批准号:
    10628917
  • 财政年份:
    2023
  • 资助金额:
    $ 0.14万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了